Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors

• Published in: PloS one Vol. 16; no. 5; p. e0251487
• Main Authors: Broering, Dieter, Shawkat, Mohamed, Albenmousa, Ali, Abaalkhail, Faisal, Alabbad, Saleh, Al-Hamoudi, Waleed, Alghamdi, Saad, Alqahthani, Saleh, Jaafari, Ahmad, Troisi, Roberto, Bzeizi, Khalid
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 13.05.2021; Public Library of Science (PLoS)
• Subjects: Attenuation; Biology and Life Sciences; Biopsy; Blood & organ donations; Body mass index; Complications; Donors; Editing; Fatty liver; Grafting; Hospitals; Informed consent; Liver; Liver diseases; Liver transplantation; Liver transplants; Magnetic resonance imaging; Measurement; Medicine; Medicine and Health Sciences; Organ donors; Pancreatic islet transplantation; Regeneration; Research facilities; Reviews; Small intestine; Steatosis; Surgery; Transplantation; Transplants & implants; Saudi Arabia; France; United States > US; Riyadh Saudi Arabia

Hepatic steatosis (HS) negatively impacts transplant outcomes in living liver donors. To date, liver biopsy is preferred for HS evaluation. This study aims to evaluate the measurement of controlled attenuation parameter (CAP) as a diagnostic tool of HS in living liver donors. Candidates recruited to...